SANTA MONICA, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Super League Enterprise, Inc. (Nasdaq: SLE) (the “Company”), a leader in engaging audiences through playable media, content, and ...

Super League Enterprise, Inc. creates and publishes content experiences and media solutions across immersive platforms in the United States and internationally. Its proprietary cloud-based ...

Biomarkers that reliably identify or even predict disease manifestations in systemic lupus erythematosus (SLE) are needed. In a recent issue of the Clinical Journal of the American Society of ...

UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

There are around 250,000 people in the EU with SLE, characterised by widespread organ damage, joint swelling, rashes, pain and fatigue, and an increased risk of death from infection and heart disease.

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy. A charitable organization with ...